Vanda Pharmaceuticals
VNDA
#7961
Rank
โ‚ฌ0.32 B
Marketcap
5,43ย โ‚ฌ
Share price
2.64%
Change (1 day)
30.88%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ35.57 Million a decrease over its 2023 earnings that were of -โ‚ฌ12.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion201.16%
2024 -โ‚ฌ35.57 Million191.43%
2023 -โ‚ฌ12.21 Million-320.45%
2022 โ‚ฌ5.53 M-84.99%
2021 โ‚ฌ36.88 M54.8%
2020 โ‚ฌ23.82 M19.42%
2019 โ‚ฌ19.95 M4.93%
2018 โ‚ฌ19.01 M-228.6%
2017 -โ‚ฌ14.79 Million-8.98%
2016 -โ‚ฌ16.25 Million-53.79%
2015 -โ‚ฌ35.16 Million-30.18%
2014 -โ‚ฌ50.35 Million173.08%
2013 -โ‚ฌ18.44 Million-25.33%
2012 -โ‚ฌ24.7 Million163.61%
2011 -โ‚ฌ9.37 Million-221.15%
2010 โ‚ฌ7.73 M-124.53%
2009 -โ‚ฌ31.53 Million-29.44%
2008 -โ‚ฌ44.68 Million-36.2%
2007 -โ‚ฌ70.02 Million21.81%
2006 -โ‚ฌ57.49 Million170.55%
2005 -โ‚ฌ21.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.72 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.80 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.26 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.22 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.50 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.39 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.46 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA